Question: Why might the CEO of the biotechnology firm discussed in
Why might the CEO of the biotechnology firm discussed in Question 7 be concerned about the firm being undervalued? Would the CEO be equally concerned if the stock were overvalued? Do you believe that the CEO would attempt to correct the market’s perception in this overvaluation case? How would you react to company concern about market under- or overvaluation if you were the firm’s auditor? Or if you were a member of the audit committee?
Answer to relevant QuestionsJoe Smith argues that “learning how to do business analysis and valuation using financial statements is not very useful, unless you are interested in becoming a financial analyst.” Comment.Coca-Cola and Pepsi are both very profitable soft drinks. Inputs for these products include corn syrup, bottles/cans, and soft drink syrup. Coca-Cola and Pepsi produce the syrup themselves and purchase the other inputs. They ...Bill Simon says, “We should get rid of the FASB and SEC since free market forces will make sure that companies report reliable information.” Do you agree? Why or why not?AMR, parent of American Airlines, provides the following footnote information on its capital and operating leases:AMR’s subsidiaries lease various types of equipment and property, primarily aircraft and airport facilities. ...When companies decide to shift from private to public financing by making an initial public offering for their stock, they are likely to face increased costs of investor communications. Given this additional cost, why would ...
Post your question